Denmark· DK-28106127018
Celecoxib "Medical Valley"
A celecoxib product containing celecoxib, registered in Denmark by Medical Valley Invest AB. The same ATC class is registered in 13 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Celecoxib is registered in 13 of 19 countries.
Countries holding a registration under ATC M01AH01 (celecoxib), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 9 of them publish a price we can compare per daily dose
Celecoxib · ATC M01AH01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of celecoxib costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), the median price runs from $0.40 in Italy to $1.31 in Switzerland — a ×3.3 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Celecoxib · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.31
- ES Spain$0.85
- IT Italy$0.40
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- CELECOXIB
- Manufacturer
- Medical Valley Invest AB
- Country
- Denmark (DK)
- ATC code
- M01AH01
- ATC class
- Celecoxib
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106127018
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
778 interactions on record for celecoxib.
Graded by severity as the source publishes them — 36 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Celecoxib · interactions on record
778 records
- 36 severe
- 349 moderate
- 4 minor
- 360 info
Most severe, free to view
- EliglustatA16AX10severe
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- CimetidineA02BA01moderate
29 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under M01AH01
Celecoxib, as other registers publish it.
- PolandAclexaKrka, d.d., Novo mesto
- PolandAclexaKrka, d.d., Novo mesto
- CzechiaACLEXAKrka, d.d., Novo mesto, Novo mesto
- CzechiaACLEXAKrka, d.d., Novo mesto, Novo mesto
- CzechiaACLEXAKrka, d.d., Novo mesto, Novo mesto
- CzechiaACLEXAKrka, d.d., Novo mesto, Novo mesto
- CzechiaACLEXAKrka, d.d., Novo mesto, Novo mesto
- CzechiaACLEXAKrka, d.d., Novo mesto, Novo mesto
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e6801c99-b364-42b5-90c2-061987cdd446 GET /v1/drugs/e6801c99-b364-42b5-90c2-061987cdd446?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "kapsler, hårde",
"source": "dkma",
"strength": "200 mg",
"auth_role": "CMS",
"dk_drugid": "28106127018",
"substance": "CELECOXIB",
"auth_procedure": "Decentral procedure",
"in_medicinpriser": true,
"registration_date_serial": "43567"
}See everything about celecoxib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.